NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyGenomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
About This Grant
This Notice of Funding Opportunity (NOFO) supports the translation of genome editing and other biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). The program spans the full translational pipeline, from therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Supported activities may include optimization of editing constructs and delivery systems; assessment of bioactivity, target engagement, durability, pharmacokinetics, and bioavailability; demonstration of in vivo efficacy; execution of safety pharmacology and toxicology studies; and development of scalable manufacturing processes, formulation strategies, and quality attributes aligned with regulatory expectations.ADRD include Frontotemporal Dementia (FTD); Lewy Body Dementias (LBD), including Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD); Vascular Contributions to Cognitive Impairment and Dementia (VCID); and Multiple Etiology Dementias (MED).
Grant Summary
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) is a National Institutes of Health grant providing up to $2.5M for municipality, school district, university. Applications are due 2028-10-10 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 1,500+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $2.5M
2028-10-10
- 1Confirm your organization is eligible for Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional): Frequently Asked Questions
Who is eligible for the Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)?
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) is offered by National Institutes of Health. The listing names these applicant types: municipality, school district, university, tribal government, nonprofit, small business. It is open to organizations nationwide unless the funder specifies otherwise. The funder's eligibility section is the authority, so confirm your organization type, location, and the population or project served against it before applying.
How much funding does the Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) provide?
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) provides up to $2.5M per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) deadline?
Applications for Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) are due 2028-10-10 (open). Because deadlines can change, verify the date with the funder, National Institutes of Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)?
To apply for Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.
Browse More Grants
Related Grants
State Veterans Home Construction Grant Program
Construction of State Home Facilities — up to $275M
Advancing Global Health
Bureau of Global Health Security and Diplomacy — up to $250M
Title X Family Planning Services Grants
Office of the Assistant Secretary for Health — up to $22M
National Produce Safety Partnership Program
Food and Drug Administration — up to $12M
Occupational Safety and Health Education and Research Centers (T42)
Centers for Disease Control and Prevention - ERA — up to $9M
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
National Institutes of Health — up to $8M